| Financial Year |
March 31 2023 |
| Monetary Funds |
1,539,998,794.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
345,074,960.26 |
| Advances to Suppliers |
1,349,649,938.11 |
| Other Receivables |
7,415,823,698.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
157,026,029,037.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,983,379,055.80 |
| Total Current Assets |
170,659,955,484.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,418,263,430.49 |
| Investment Properties |
25,825,043,123.00 |
| Fixed Assetes |
3,049,593,063.66 |
| Under-construction Projects |
3,014,443,432.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,384,827,231.70 |
| R&D expenses |
-- |
| Goodwill |
38,721,779.22 |
| Long-Term Deferred and Prepaid Expenses |
21,301,295.63 |
| Deferred Income Tax Assets |
3,201,413,996.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
44,926,701,456.89 |
| Total Assets |
215,586,656,941.28 |
| Short-Term Loans |
4,977,392,398.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,032,011,431.21 |
| Accounts Received In Advance |
241,830,802.75 |
| Employee Compensation Payable |
118,160,059.83 |
| Taxes Payable |
6,377,183,794.45 |
| Interest Payable |
24,408,252,582.34 |
| Dividend Payable |
156,011,158.96 |
| Other payables |
54,758,648,727.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,276,191,732.30 |
| Other Current Liabilities |
5,802,655,496.46 |
| Sub-Total of Current Liabilities |
186,121,153,271.05 |
| Long-term Loans |
18,732,689,360.35 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,988,872.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
480,605,704.78 |
| Deferred Income Tax Liabilities |
2,383,306,346.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,643,627,857.74 |
| Total Liabilities |
207,764,781,128.79 |
| Paid-In Capital(Or Share Stock) |
2,488,901,440.00 |
| Capital Surplus |
2,272,504,298.07 |
| Surplus Reserve |
272,978,729.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,116,060,118.35 |
| Minority Stockholder's Interest |
3,950,381,282.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,871,494,529.67 |
| Owner's Equity（Stockholder's Equity） |
7,821,875,812.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
215,586,656,941.28 |
